BodyGuardian Remote Monitoring System vs PMcardio

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Preventice Technologies (now Boston Scientific Cardiac Diagnostics)
VS
by Powerful Medical

AI Verdict

Both tools leverage AI for cardiac condition detection and monitoring, making them adjacent in their core function. BodyGuardian focuses on continuous, long-term remote monitoring of arrhythmias via a wearable device, while PMcardio specializes in rapid, point-of-care ECG interpretation for a broader range of cardiac conditions, including STEMI and reduced LVEF. The choice between them depends on whether continuous ambulatory monitoring or immediate, comprehensive ECG analysis is the primary need.

Choose BodyGuardian Remote Monitoring System if…

Choose BodyGuardian Remote Monitoring System if you need continuous, long-term monitoring of ambulatory patients for non-lethal cardiac arrhythmias. This wearable device excels at collecting comprehensive physiological data (ECG, heart rate, respiration rate, activity level) over extended periods, allowing for flexible monitoring that combines mobile cardiac telemetry, event monitoring, and Holter monitoring in one device. It's ideal for detecting infrequent or transient arrhythmias that might be missed during shorter in-clinic observations, providing a constant connection between patients and their care teams.

View BodyGuardian Remote Monitoring System →

Choose PMcardio if…

Choose PMcardio if you require rapid, AI-powered interpretation of 12-lead ECGs at the point of care for immediate assessment of over 50 cardiac conditions. This mobile and web-based platform is particularly well-suited for acute care settings, emergency medicine, and primary care where quick, expert-level ECG analysis is crucial for timely diagnosis and treatment decisions, including the detection of critical conditions like STEMI/OMI and reduced LVEF.

View PMcardio →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature BodyGuardian Remote Monitoring System PMcardio
Pricing Not publicly available Freemium
Deployment Cloud-based platform with wearable device and mobile application components. Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
FDA Status 1 AI-estimated Pending AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

BodyGuardian Remote Monitoring System (Tool A) emphasizes a patient-centered design with a small, waterproof, and comfortable wearable sensor that allows for uninterrupted daily activities like showering and exercise. This focus on patient comfort and ease of wear likely leads to higher compliance and a better overall user experience for the patient. While PMcardio (Tool B) offers a user-friendly mobile app, the primary interaction is through taking photos of ECGs, which may introduce an extra step and potential for error compared to continuous, automatic data collection from a wearable device.

Clinical Value

Tie

PMcardio (Tool B) demonstrates superior clinical value by interpreting over 50 cardiac conditions, including advanced detection of STEMI/OMI and reduced LVEF, and has been validated in more than 25 clinical studies. Its AI explainability feature (ECGxplainu2122) also enhances clinician trust and understanding of the diagnoses. While BodyGuardian (Tool A) is FDA-cleared for detecting and monitoring non-lethal cardiac arrhythmias, its published clinical validation focuses primarily on heart rate and respiration rate accuracy, with some doubts regarding the clinical meaning and validity of activity and respiration data.

Pricing & Value

Tie

PMcardio (Tool B) offers a transparent freemium model, including a free plan with 5 ECG analyses per month and a Pro Plan for unlimited use and advanced features at a publicly available price. This allows users to try the product and choose a plan that fits their needs. BodyGuardian (Tool A) does not publicly disclose its pricing, requiring direct contact with the vendor, which can be a barrier to understanding its value proposition.

Enterprise Readiness

Tie

PMcardio (Tool B) explicitly offers enterprise integrations with EHR/CVIS and EMS systems, along with custom pricing and features for organizations, indicating a strong focus on large-scale deployment. It also highlights configurable user permissions and security protections for enterprise clients. BodyGuardian (Tool A) mentions a cloud-based platform and physician review via web portal or dedicated mobile application, and EMR integrations, suggesting enterprise capabilities, but PMcardio's offerings are more explicitly detailed for enterprise-level deployment.

Innovation

Tie

PMcardio (Tool B) showcases greater innovation with its AI explainability feature (ECGxplainu2122), providing visual heatmaps to illustrate the AI's decision-making process, which fosters trust and serves as an educational tool. It also focuses on advanced detection of subtle ECG patterns like Occlusion Myocardial Infarction (OMI) that can be missed by standard interpretation. BodyGuardian (Tool A) focuses on combining multiple monitoring technologies into a single wearable device and continuous data transmission, which is innovative in its own right, but PMcardio's explainable AI and advanced diagnostic capabilities represent a more cutting-edge AI innovation.

Support & Docs

Tie

PMcardio (Tool B) provides readily accessible resources such as a Help Center, FAQ, and blog, indicating a comprehensive approach to user support and documentation. They also offer direct support channels for individuals and organizations. BodyGuardian (Tool A) offers patient resources, including videos, guides, and FAQs, and mentions customer service for billing, but a comprehensive suite of documentation and support for clinicians or enterprise users is not as explicitly detailed.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature BodyGuardian Remote Monitoring System PMcardio
Company Preventice Technologies (now Boston Scientific Cardiac Diagnostics) Powerful Medical
Key Functionality Wearable body sensor for continuous cardiac monitoring; Detects and monitors non-lethal cardiac arrhythmias; Collects ECG, heart rate, respiration rate, and activity level data; Combines mobile cardiac telemetry, event monitoring, and Holter monitoring in one device. Instant AI-powered ECG interpretations; Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders); Automatic analysis of heart rate, axis, P wave, PR, QRS, and QT/QTc intervals.
Specialties Cardiology, Pediatrics Cardiology, Emergency Medicine, Internal Medicine
AI/Analytics Sophisticated algorithms, including BeatLogic deep learning AI for accurate rhythm analysis AI that reads ECGs in seconds; Queen of Heartsu2122 - STEMI and OMI Detection; LVsenseu2122 - Reduced LVEF Detection; ECGxplainu2122 - Visual AI Explainability with heatmaps; Core AI - Detects 36 core diagnoses

Videos

Demos, reviews, and walkthroughs featuring BodyGuardian Remote Monitoring System and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

BodyGuardian Remote Monitoring System integrates with a cloud-based platform and offers physician review via a web portal or dedicated mobile application, implying data accessibility for EHR integration. PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, suggesting a more direct and potentially deeper level of integration for automated data flow and clinical workflows.
BodyGuardian Remote Monitoring System utilizes BeatLogic deep learning AI for accurate rhythm analysis in detecting non-lethal cardiac arrhythmias. PMcardio is clinically validated in over 25 studies and detects over 50 cardiac conditions, including STEMI/OMI, rhythms, and reduced LVEF, with AI-powered ECG interpretations.
BodyGuardian Remote Monitoring System is specifically designed for Cardiology and Pediatrics, focusing on continuous cardiac monitoring for arrhythmias. PMcardio, with its broader ECG interpretation capabilities for over 50 cardiac conditions, is suitable for Cardiology, Emergency Medicine, and Internal Medicine.
BodyGuardian involves a wearable sensor and mobile application for data collection, with physician review via a portal or app, suggesting a moderate learning curve for device application and data interpretation. PMcardio operates as a mobile app and web platform providing instant AI-powered ECG interpretations, which may imply a relatively quicker learning curve for interpretation, especially with features like visual AI explainability.
While BodyGuardian's description doesn't explicitly detail audit trail features, its cloud-based platform and physician review portal likely include some form of activity logging. PMcardio's 'extended report history' feature suggests a robust record-keeping capability, which could contribute to a comprehensive audit trail for ECG analyses and interpretations.
BodyGuardian's cloud-based platform and mobile application components inherently support multi-site access for data review and management. PMcardio's enterprise integrations with EHR/CVIS and EMS systems, along with its web platform, are well-suited for standardized deployment and use across multiple clinical sites within a larger healthcare system.

Backers

Who funded each tool's parent company.

PMcardio

AI Tool Finder
AI-powered search. Results may not be comprehensive.